Notificação de entrada na fase nacional - PCT
#1.3
03/31/2026
RPI 2882
Application data
Number
112025012134Type
Filing
Publication
PCT
IB2023062818 Examination has not been requested yet. Without that request by 12/15/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:12/15/2026(112 days left)
Latest action published by the INPI: 03/31/2026. We update with every new RPI gazette, published weekly.
Applicants
PHEON THERAPEUTICS LTD
GB
Inventors
C. H. (pessoa física)
GB
L. Z. (pessoa física)
GB
IPC Classification
Priority claims
US
63/387,819 · 12/16/2022
Abstract
ANTICORPOS PARA PROTEÍNA 1 CONTENDO DOMÍNIO CUB (CDCP1) E USOS DESTES. A presente invenção refere-se a anticorpos e fragmentos de ligação ao antígeno destes que se ligam ao CDCP1 humano. Os anticorpos divulgados são, portanto, úteis para o tratamento de câncer, sozinhos ou em combinação com outros agentes.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
03/31/2026
RPI 2882
#1.1
07/22/2025
RPI 2846
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.